Stock RV6 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Charles River Laboratories International, Inc. BOERSE MUENCHEN

Equities

RV6

US1598641074

Real-time BOERSE MUENCHEN
Other stock markets
 02:00:22 2024-06-27 EDT 		5-day change 1st Jan Change
192.8 EUR 0.00% Intraday chart for Charles River Laboratories International, Inc. -0.67% -10.09%
06-25 Charles River Laboratories, Gates Institute Collaborate on Lentiviral Vector Manufacturing MT
06-25 Charles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute at University of Colorado Anschutz Medical Campus CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Charles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute at University of Colorado Anschutz Medical Campus
BU
Charles River and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing Alliance for Gene-Modified Cell Therapy
BU
Charles River Laboratories, in Collaboration With MatTek Corporation, Awarded Grant from the Foundation for Chemistry Research and Initiatives to Advance Research Alternatives
BU
Charles River Laboratories Expands Access to CRADL Contract Vivarium Space in Somerville
AQ
Charles River Laboratories Expands Access to CRADL® Contract Vivarium Space in Somerville
BU
Charles River Laboratories Announces Development of Nonclinical Virtual Control Groups with Sanofi to Reduce the Use of Animals in Research
BU
Charles River Laboratories to Present at William Blair and Jefferies Conferences
BU
Charles River Launches Viral Vector Tech Transfer Program to Safeguard Gene Therapy Development
BU
Charles River: Q1 Earnings Snapshot
AQ
Charles River Laboratories Announces First-Quarter 2024 Results
BU
Charles River Launches Viral Vector Reference Materials to Streamline the Transition to GMP
BU
Charles River Laboratories International : Proxy Supplement Filed April 24, 2024
PU
Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally
BU
Charles River Laboratories International : 2023 Corporate Citizenship Report
PU
Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing
BU
Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call
AQ
Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call
BU
Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology
BU
Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics
BU
Charles River to Perform Plasmid Production for Ship of Theseus
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CRL Stock
  4. RV6 Stock
  5. News Charles River Laboratories International, Inc.
  6. Press Releases